SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-217476
Filing Date
2022-08-10
Accepted
2022-08-10 17:10:59
Documents
20
Period of Report
2022-08-09
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d388891d8k.htm   iXBRL 8-K 40515
2 EX-99.1 d388891dex991.htm EX-99.1 47425
3 EX-99.2 d388891dex992.htm EX-99.2 20900
4 EX-99.3 d388891dex993.htm EX-99.3 3285
5 EX-99.4 d388891dex994.htm EX-99.4 12036
9 GRAPHIC g388891dsp020.jpg GRAPHIC 139860
10 GRAPHIC g388891dsp021.jpg GRAPHIC 113341
11 GRAPHIC g388891dsp022.jpg GRAPHIC 129767
12 GRAPHIC g388891g0811004112192.jpg GRAPHIC 2726
  Complete submission text file 0001193125-22-217476.txt   817074

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA gmtx-20220809.xsd EX-101.SCH 2879
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE gmtx-20220809_lab.xml EX-101.LAB 17980
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE gmtx-20220809_pre.xml EX-101.PRE 11274
14 EXTRACTED XBRL INSTANCE DOCUMENT d388891d8k_htm.xml XML 3405
Mailing Address 300 ONE KENDALL SQUARE, 3RD FLOOR CAMBRIDGE MA 02139
Business Address 300 ONE KENDALL SQUARE, 3RD FLOOR CAMBRIDGE MA 02139 (617) 401-4400
Gemini Therapeutics, Inc. /DE (Filer) CIK: 0001816736 (see all company filings)

IRS No.: 851613057 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39438 | Film No.: 221152684
SIC: 2834 Pharmaceutical Preparations